Mohammedi, Kamel
Université de Bordeaux · Inserm · Biologie des maladies cardiovasculaires
6 papers on CoChatORCID 0000-0001-6139-1197
Most cited papers
- Verified
Comparative effects of microvascular and macrovascular disease on the risk of major outcomes in patients with type 2 diabetes
Mohammedi, K., Woodward, M., Marre, M., Colagiuri, S., Cooper, M., Harrap, S., Mancia, G., Poulter, N., Williams, B., Zoungas, S., et al. (2017) · Cardiovascular Diabetology
Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 111
- Verified
Cause-specific mortality in diabetes: recent changes in trend mortality
Khalil, C. A., Roussel, R., Mohammedi, K., Danchin, N., & Marre, M. (2012) · European Journal of Preventive Cardiology
Diabetes, Cardiovascular Risks, and LipoproteinsDiabetes Management and Research
Cited by 98
- Verified
Plasma Copeptin and Renal Outcomes in Patients With Type 2 Diabetes and Albuminuria
Velho, G., Bouby, N., Hadjadj, S., Matallah, N., Mohammedi, K., Fumeron, F., Potier, L., Bellili-Munoz, N., Taveau, C., Alhenc-Gelas, F., et al. (2013) · Diabetes Care
Chronic Kidney Disease and DiabetesAcute Kidney Injury Research
Cited by 89
- Verified
Protection against stroke with glucagon-like peptide-1 receptor agonists: a comprehensive review of potential mechanisms
Vergès, B., Aboyans, V., Angoulvant, D., Boutouyrie, P., Cariou, B., Hyafil, F., Mohammedi, K., & Amarenco, P. (2022) · Cardiovascular Diabetology
Diabetes Treatment and ManagementAcute Ischemic Stroke Management
Cited by 72
- Verified
Plasma Extracellular Superoxide Dismutase Concentration, Allelic Variations in the SOD3 Gene and Risk of Myocardial Infarction and All-Cause Mortality in People with Type 1 and Type 2 Diabetes
Mohammedi, K., Bellili-Muñoz, N., Marklund, S. L., Driss, F., Le Nagard, H., Patente, T. A., Fumeron, F., Roussel, R., Hadjadj, S., Marre, M., et al. (2015) · Cardiovascular Diabetology
Glutathione Transferases and PolymorphismsParaoxonase enzyme and polymorphisms
Cited by 63
- Verified
Prognostic value of plasma MR-proADM vs NT-proBNP for heart failure in people with type 2 diabetes: the SURDIAGENE prospective study
for the SURDIAGENE Study Group, Fraty, M., Velho, G., Gand, E., Fumeron, F., Ragot, S., Sosner, P., Mohammedi, K., Gellen, B., Saulnier, P.-J., et al. (2018) · Diabetologia
Heart Failure Treatment and ManagementGDF15 and Related Biomarkers
Cited by 22
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free